MicroPort NeuroTech (HKG:2172) granted a three-year non-exclusive license to majority shareholder MicroPort Scientific (HKG:0853) to commercialize its medical devices overseas, according to a bourse filing Friday.
MicroPort NeuroTech shares gained nearly 4% in midday trade Monday, while MicroPort Scientific shares rose over 2%.
The agreement runs until June 26, 2028, MicroPort NeuroTech said.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.